Prot# 087-CL-301: A Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Conivaptan in Symptomatic Acute Decompensated Heart Failure (ADHF) Subjects with Hyponatremia

Project: Research project

Project Details

StatusFinished
Effective start/end date4/2/09 → 7/28/11

Funding

  • Jubilant Clinsys, Inc. (087-CL-301 // 087-CL-301)
  • Astellas Pharma Global Development, Inc. (087-CL-301 // 087-CL-301)